Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma.
BACKGROUND
Previous research has demonstrated that fish oil supplementation has a protective effect on exercise-induced bronchoconstriction (EIB) in elite athletes, which may be attributed to its antiinflammatory properties. Since EIB in asthma involves proinflammatory mediator release, it is feasible that fish oil supplementation may reduce the severity of EIB in asthmatic subjects.


OBJECTIVE
To determine the efficacy of fish oil supplementation on severity of EIB in subjects with asthma.


METHODS
Randomized, double-blind, crossover study.


METHODS
Lung function and exercise testing in a university research laboratory.


METHODS
Sixteen asthmatic patients with documented EIB entered the study on their normal diet and then received either fish oil capsules containing 3.2 g of eicosapentaenoic acid and 2.0 g of docohexaenoic acid (fish oil diet, n = 8) or placebo capsules (placebo diet, n = 8) daily for 3 weeks. At the beginning of the study (normal diet) and at the end of each treatment phase, the following pre-exercise and postexercise measures were assessed: (1) pulmonary function; (2) induced sputum differential cell count percentage and proinflammatory eicosanoid metabolite (leukotriene C4 [LTC4]-leukotriene E4 [LTE4] and prostaglandin D2 [PGD2]) and cytokine (interleukin [IL]-1beta and tumor necrosis factor [TNF]-alpha) concentrations; and (3) eicosanoid metabolites leukotriene B4 (LTB4) and leukotriene B5 (LTB(5)) generation from activated polymorphonuclear leukocytes (PMNLs).


RESULTS
On the normal and placebo diet, subjects exhibited EIB. However, the fish oil diet improved pulmonary function to below the diagnostic EIB threshold, with a concurrent reduction in bronchodilator use. Induced sputum differential cell count percentage and concentrations of LTC4-LTE4, PGD2, IL-1beta, and TNF-alpha were significantly reduced before and following exercise on the fish oil diet compared to the normal and placebo diets. There was a significant reduction in LTB4 and a significant increase in LTB5 generation from activated PMNLs on the fish oil diet compared to the normal and placebo diets.


CONCLUSIONS
Our data suggest that fish oil supplementation may represent a potentially beneficial nonpharmacologic intervention for asthmatic subjects with EIB.
Mickleborough
Timothy D
TD
Human Performance and Exercise Biochemistry Laboratory, Department of Kinesiology, Indiana University, 1025 E Seventh St, HPER 112, Bloomington, IN 47401, USA. tmickleb@indiana.edu
Lindley
Martin R
MR
Ionescu
Alina A
AA
Fly
Alyce D
AD
D000328:Adult; D001249:Asthma / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D016084:Bronchoconstriction / Q000187:drug effects*; D018592:Cross-Over Studies; D019587:Dietary Supplements; D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D005080:Exercise Test / Q000009:adverse effects; D005260:Female; D005395:Fish Oils / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D007975:Leukotriene B4 / Q000031:analogs & derivatives / Q000378:metabolism; D008297:Male; D013183:Sputum / Q000166:cytology / Q000378:metabolism; D016896:Treatment Outcome
D005395:Fish Oils; D007975:Leukotriene B4; C040212:leukotriene B5; D015118:Eicosapentaenoic Acid